ITIH4 and breast carcinoma: Accordingly, van Winden and colleagues (2010) [27] and Opstal-van Winden and colleagues (2011) [28] discovered that isoform 1 of the heavy chain of inter-alpha trypsin inhibitor H4 (ITIH4) presented elevated values in pre-diagnosis breast cancer and was already altered up to three years before cancer detection.